Ticker

Institutional and Insider Ownership 44.0% of Vincerx Pharma shares are held by institutional investors. Comparatively, 5.7% of Ampio Pharmaceuticals shares are held by institutional investors. 15.6% of Vincerx Pharma shares are held by insiders. Comparatively, 3.3% of Ampio Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments

Profitability This table compares Trevena and Ampio Pharmaceuticals' net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Trevena N/A N/A -119.55% Ampio Pharmaceuticals N/A N/A N/A Earnings and Valuation This table compares Trevena and Ampio Pharmaceuticals"s top-line revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio

Volatility and Risk Graybug Vision has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. Comparatively, Ampio Pharmaceuticals has a beta of 5.57, indicating that its share price is 457% more volatile than the S&P 500. Valuation and Earnings This table compares Graybug Vision and Ampio Pharmaceuticals"s